We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Donald Berry

Donald A Berry PhD

Professor, Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Donald Berry is professor in the Department of Biostatistics of the University of Texas M.D. Anderson Cancer Center. He received his Ph.D. in statistics from Yale University and has served on the faculty the University of Minnesota and Duke University. He has held endowed positions at Duke and M.D. Anderson. He has authored many books on biostatistics and over 400 peer-reviewed articles. He is a Thomson Reuters Highly Cited Researcher in recognition of ranking among the top 1% of most cited researchers in Clinical Medicine. He has received numerous research grants from the NIH and NSF and is Fellow of the American Statistical Association, the Institute of Mathematical Statistics, and the International Society of Bayesian Analysis. He has designed many innovative clinical trials in cancer and in virtually every other therapeutic area, including adaptive Bayesian trials. He is founder and co-owner of Berry Consultants, a company that has designed and helped run innovative trials for pharmaceutical companies, medical device companies, patient advocacy groups, and for international consortia in Alzheimer’s disease, cancer, Ebola, sepsis, community-acquired pneumonia and other diseases.

Disclosures

Donald Berry is founder and co-owner of Berry Consultants LLC, a company that designs and helps run Bayesian adaptive clinical trials for pharmaceutical companies, medical device companies, patient advocacy groups, and international consortia. Genentech/F.Hoffmann-La Roche, Ltd. is a client of Berry Consultants.